Mrs. Anna Madden Mcintosh, MA-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15808 Kelly Park Cir, Huntersville, NC 28078 Phone: 704-248-0786 |
Ms. Julie Michelle Wicher, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6918 Carrington Pointe Dr, Huntersville, NC 28078 Phone: 704-796-8405 |
Mrs. Meredith Fisher Menudier Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16455 Statesville Rd, Huntersville, NC 28078 Phone: 704-801-3719 Fax: 704-801-3705 |
Ms. Patricia Ann Archer, MSP, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11026 Asbury Chapel Rd, Huntersville, NC 28078 Phone: 704-575-4222 Fax: 704-875-7112 |
Mrs. Gina Marie Brun, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 720 Mercer Pl, Huntersville, NC 28078 Phone: 704-948-5681 |
Rosemary Sherard Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14611 S Brent Dr, Huntersville, NC 28078 Phone: 704-965-0848 |
Mollie Carlson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 320 Seagle St, Huntersville, NC 28078 Phone: 704-752-1616 |
Ms. Kathryn Marie Underwood Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8509 Glade Ct, Huntersville, NC 28078 Phone: 412-251-8142 |
Euphony Speech And Orofacial Myology, Pllc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 16501 Northcross Dr Ste D, Huntersville, NC 28078 Phone: 704-800-5232 Fax: 704-765-4822 |
Dionne Mashawn Spence, MA SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16455 Statesville Rd, Huntersville, NC 28078 Phone: 704-801-3719 Fax: 704-801-3705 |
Mrs. Karen M Mowers, M.A. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8820 Blooming Arbor St, Huntersville, NC 28078 Phone: 704-619-2167 Fax: 704-948-6963 |
Denise Elliott Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16405 Northcross Dr, Suite G-2, Huntersville, NC 28078 Phone: 704-550-4954 |
Rehab Builders Of The Carolinas, Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13016 Eastfield Rd, Ste 200-336, Huntersville, NC 28078 Phone: 704-274-9062 Fax: 866-268-3797 |
Mrs. Shea H Bradford, MSP/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4022 Conner Glenn Dr, Huntersville, NC 28078 Phone: 704-992-6651 |
Christy L Strand, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10030 Gilead Rd, Suite B100, Huntersville, NC 28078 Phone: 704-316-5500 Fax: 704-316-2463 |
Madison Cross Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16455 Statesville Rd Ste 300, Huntersville, NC 28078 Phone: 704-801-3719 |
Meeting Milestones Speech Services, Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6842 Colonial Garden Dr, Huntersville, NC 28078 Phone: 516-384-2102 |
Leigh Ruckdeschel Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16405 Northcross Dr, Suite G-2, Huntersville, NC 28078 Phone: 704-439-3406 |
Abby Burkhard Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13825 Hunton Ln # 6190, Huntersville, NC 28078 Phone: 704-897-2700 |
Allison W. Warren, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10030 Gilead Rd, Suite B100, Huntersville, NC 28078 Phone: 704-316-5500 Fax: 704-316-2463 |
News Archive
Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced top-line results from a Phase 2b clinical trial of TC-5619 as an augmentation therapy for the treatment of negative symptoms of schizophrenia.
Patients benefitted from an important design element in the pivotal phase III clinical trial that led to Food and Drug Administration and worldwide regulatory approval of sunitinib for the treatment of gastrointestinal stromal tumors resistant to the only other available therapy, according to a study in Clinical Cancer Research, a journal of the American Association for Cancer Research.
A study from Switzerland suggests that men who have surgery for prostate cancer appear less likely to die of the disease within 10 years than men who choose other treatment options, especially if they are younger or have cancers with certain tumor cell characteristics, according to a report in the Oct. 8 issue of Archives of Internal Medicine.
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced 52-week results from PALACE 1, the Company's first phase III study in psoriatic arthritis at the European Congress of Rheumatology annual meeting in Madrid, Spain.
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced FDA approval of bacitracin for injection, USP (bacitracin), an anti-infective product used to treat pneumonia and empyema. Bacitracin will be offered in a 50,000 MU, AP-rated, preservative-free, latex-free, single-dose vial packaged both individually and in packages of ten.
› Verified 3 days ago